MRI-efficacy of Abatacept in patients with rheumatoid arthritis [MIYAKO study]

Trial Profile

MRI-efficacy of Abatacept in patients with rheumatoid arthritis [MIYAKO study]

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Mar 2017

At a glance

  • Drugs Abatacept (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms MIYAKO study
  • Most Recent Events

    • 02 Feb 2016 Status changed from active, no longer recruiting to completed according to results presented at the 79th American College of Rheumatology and the 50th Annual Meeting of the Association of Rheumatology and Health Professionals.
    • 28 Feb 2015 Planned number of patients changed from 40 to NULL.
    • 28 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top